Feedback / Questions
RNDP-001 - Kenai Therap
https://www.prnewswire.com/news-releases/kenai-therapeutics-announces-first-patient-dosed-in-phase-1-replace-clinical-trial-of-neuron-replacement-cell-therapy-rndp-001-for-idiopathic-parkinsons-disease-302640518.html
Dec 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next